Biopharmaceutical News and Research

RSS
EMA recommends first all-oral treatment to tackle deadly sleeping sickness

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

Study examines effects of walking exercise training on cognitive function in people with MS

Study examines effects of walking exercise training on cognitive function in people with MS

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Mice study shows antibiotics are not always necessary to cure sepsis

Mice study shows antibiotics are not always necessary to cure sepsis

Beckman Coulter Life Sciences announces new research-focused website

Beckman Coulter Life Sciences announces new research-focused website

Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa 2018

Insilico to present advances in artificial intelligence at the Healthcare Innovation Summit Africa 2018